Correlation Between Pmv Pharmaceuticals and Vitru
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Vitru at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Vitru into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Vitru, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Vitru and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Vitru. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Vitru.
Diversification Opportunities for Pmv Pharmaceuticals and Vitru
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pmv and Vitru is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Vitru in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitru and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Vitru. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitru has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Vitru go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Vitru
If you would invest 1,650 in Vitru on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Vitru or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Vitru
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Vitru |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pmv Pharmaceuticals and Vitru Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Vitru
The main advantage of trading using opposite Pmv Pharmaceuticals and Vitru positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Vitru can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitru will offset losses from the drop in Vitru's long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| Vitru vs. Universal Technical Institute | Vitru vs. ATA Creativity Global | Vitru vs. Cogna Educacao SA | Vitru vs. Sunlands Technology Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |